Market Cap

Albireo Pharma, Inc. Market Capitalization:

$910.7 Million

USD as of Jan. 1, 2023

business Albireo Pharma, Inc. Company Profile

Albireo Pharma, Inc. Main Stock Listing

NASDAQ: ALBO

Market Capitalization History of Albireo Pharma, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Albireo Pharma, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2023 $910.7 M 54.09%
Jan. 1, 2022 $591.0 M -22.31%
Jan. 1, 2021 $760.7 M 61.54%
Jan. 1, 2020 $470.9 M -12.69%
Jan. 1, 2019 $539.4 M -25.71%
Jan. 1, 2018 $726.1 M 78.39%
Jan. 1, 2017 $407.0 M 161.60%
Jan. 1, 2016 $155.6 M -83.44%
Jan. 1, 2015 $939.7 M -44.49%
Jan. 1, 2014 $1.69 B 0.74%
Jan. 1, 2013 $1.68 B 8.87%
Jan. 1, 2012 $1.54 B -72.07%
Jan. 1, 2011 $5.53 B -44.64%
Jan. 1, 2010 $9.98 B -9.28%
Jan. 1, 2009 $11.00 B -75.21%
Jan. 1, 2008 $44.39 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

Albireo Pharma, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Albireo Pharma, Inc. has the following listings and related stock indices.


Stock: NASDAQ: ALBO

Stock: FSX: BDQM

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.